$BNR
Burning Rock Biotech Limited American Depositary Shares
XNAS•Health Care•Services-Medical Laboratories
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateBurning Rock Biotech Limited American Depositary Shares
XNAS•Health Care•Services-Medical Laboratories
Why is BNR up today? It is at $14.93 (+10.43%), and our scanner flagged it 14 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment BNR spikes, and full due diligence on BNR — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $BNR 14 times in the last 30 days. Create a free account to track $BNR, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on BNR from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Han Yusheng Director | Bought (open market) | +25K 0.3% of company | added 0.1% | 18.40M | $199K at $8.00 | Jun 26, 26 |
Han Yusheng Director | Bought (open market) | +250K 2.8% of company | added 1.4% | 18.38M | $2.0M at $8.00 | Jun 24, 26 |
Han Yusheng Director | Bought (open market) | +6K 0.07% of company | added <0.1% | 18.13M | $45K at $7.50 | Jun 23, 26 |
Han Yusheng Director | Bought (open market) | +105K 1.2% of company | added 0.6% | 18.12M | $780K at $7.45 | Jun 22, 26 |
Han Yusheng Director | Bought (open market) | +111K 1.3% of company | added 0.6% | 18.02M | $1000K at $9.00 | Jun 16, 26 |
Han Yusheng Director | Bought (open market) | +210K 2.4% of company | added 1.2% | 17.91M | $1.9M at $9.25 | Jun 12, 26 |
Han Yusheng Director | Bought (open market) | +25K 0.3% of company | added 0.1% | 17.70M | $216K at $8.74 | Jun 11, 26 |
Han Yusheng Director | Bought (open market) | +315K 3.6% of company | added 1.8% | 17.67M | $5.5M at $17.36 | Mar 31, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in services-medical laboratories, closest in size first.
Here is the latest on BNR from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
BNR last traded at $14.93, up 10.43% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The BNR Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged BNR 14 times in the last 30 days.
BNR (Burning Rock Biotech Limited American Depositary Shares) trades on XNAS, with a market cap of about $125M in the Services-Medical Laboratories sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge BNR for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$BNR discussion
Sign in to ask a question or join the discussion.